We read with interest the recent study by van Vugtet al.1whichadds data to the debate on a desirable improvement in thepolicy for the optimization of the organ allocation criteria inliver transplant (LT) setting.The aim of this multicenter registry based European studywas initially to investigate whether sarcopenia is a risk factor,independent of the model for end-stage liver disease (MELD)score, for waiting list mortality.
May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease? / Lucidi, Cristina; Lattanzi, Barbara; Riggio, Oliviero; Merli, Manuela. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 68:6(2018), pp. 1324-1325. [10.1016/j.jhep.2018.02.035]
May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease?
Lucidi, CristinaPrimo
Writing – Original Draft Preparation
;Lattanzi, BarbaraSecondo
Formal Analysis
;Riggio, OlivieroPenultimo
Supervision
;Merli, Manuela
Ultimo
Writing – Review & Editing
2018
Abstract
We read with interest the recent study by van Vugtet al.1whichadds data to the debate on a desirable improvement in thepolicy for the optimization of the organ allocation criteria inliver transplant (LT) setting.The aim of this multicenter registry based European studywas initially to investigate whether sarcopenia is a risk factor,independent of the model for end-stage liver disease (MELD)score, for waiting list mortality.| File | Dimensione | Formato | |
|---|---|---|---|
|
Merli_may-sarcopenia_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
160.13 kB
Formato
Adobe PDF
|
160.13 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
